Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
15,242,452
-
Share change
-
-1,057,977
-
Total reported value
-
$308,003,839
-
Put/Call ratio
-
163%
-
Price per share
-
$20.21
-
Number of holders
-
78
-
Value change
-
-$24,336,115
-
Number of buys
-
40
-
Number of sells
-
36
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2021
As of 31 Mar 2021,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,242,452 shares.
The largest 10 holders included
ARK Investment Management LLC, Capital International Investors, CREDIT SUISSE AG/, CAPITAL INTERNATIONAL INC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Capital World Investors, Bpifrance SA, FMR LLC, and Capital Impact Advisors, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.